Cargando…

Double-Blind, Placebo-Controlled, Randomized Study Comparing 0.0003% Calcitriol with 0.1% Tacrolimus Ointments for the Treatment of Endemic Pityriasis Alba

Background. Pityriasis alba (PA) is a frequent cause of consultation in tropical areas due to its chronic course, frequent relapses, and notorious hypopigmented lesions in pediatric dark skin populations. Currently, no treatment is widely accepted. Objective. To assess the efficacy of 0.0003% calcit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moreno-Cruz, Berenice, Torres-Álvarez, Bertha, Hernández-Blanco, Diana, Castanedo-Cazares, Juan Pablo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3346967/ https://www.ncbi.nlm.nih.gov/pubmed/22577371 http://dx.doi.org/10.1155/2012/303275

Ejemplares similares

Long-term use of 0.003% tacrolimus suspension for treatment of vernal keratoconjunctivitis
por: Al-Amri, Abdulrahman Mohammed, et al.
Publicado: (2017)

Topical tacrolimus 0.1% ointment for treatment of cutaneous Crohn’s Disease
por: Rice, Shantini A, et al.
Publicado: (2013)

Maintenance Therapy of Facial Seborrheic Dermatitis with 0.1% Tacrolimus Ointment
por: Kim, Hye One, et al.
Publicado: (2015)

Comparision of efficacy and safety of 0.03% and 0.1% tacrolimus ointment in children with vernal keratoconjunctivitis
por: Saha, Bhawesh Chandra, et al.
Publicado: (2023)

EFFECT OF 0.1% TACROLIMUS OINTMENT IN LOCALIZED VITILIGO: AN OPEN UNCONTROLLED TRIAL
por: Bhuvana, K, et al.
Publicado: (2011)

Treatment of balanitis of Zoon's with tacrolimus 0.03% ointment
por: Chander, Ram, et al.
Publicado: (2009)

The Use of Topical Tacrolimus 0.1% Skin Ointment for Anterior Segment Conditions: A Case Series
por: Abeysiri, Poorna, et al.
Publicado: (2010)

Efficacy of topical application of 0.03% tacrolimus eye ointment in the management of allergic conjunctivitis
por: Hazarika, Ajit Kumar, et al.
Publicado: (2015)

Successful Treatment of Recalcitrant Granuloma Gluteale Infantum with Topical Tacrolimus 0.03% Ointment
por: Leung, Alexander K. C., et al.
Publicado: (2021)

Kaposi's Varicelliform Eruption During Long-term Treatment of Rosacea with 0.03% Tacrolimus Ointment
por: Chen, Qi-Quan, et al.
Publicado: (2015)

Therapeutic Effect of 0.03% Tacrolimus Ointment for Ocular Graft versus Host Disease and Vernal Keratoconjunctivitis
por: Ryu, Eun Hye, et al.
Publicado: (2012)

Tacrolimus 0.03% ointment for treatment of paediatric lichen sclerosus: a case series and literature review
por: Mazzilli, Sara, et al.
Publicado: (2018)

Therapeutic effects of topical 0.03% Tacrolimus ointment in children with refractory vernal keratoconjunctivitis in Middle East
por: Fiorentini, Sandra Flavia, et al.
Publicado: (2019)

Long-term results of topical 0.02% tacrolimus ointment for refractory ocular surface inflammation in pediatric patients
por: Koh, Kyungmin, et al.
Publicado: (2021)

Tacrolimus ointment in the management of atopic dermatitis
por: Baldo, Antonello, et al.
Publicado: (2009)

Tacrolimus Ointment for Treatment of Vernal Keratoconjunctivitis
por: Al-Amri, Abdulrahman M., et al.
Publicado: (2016)

Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial
por: Dupuis-Girod, Sophie, et al.
Publicado: (2020)

Comparison of topical clobetasol propionate 0.05% and topical tacrolimus 0.1% in the treatment of cutaneous lichen planus
por: Özkur, Ezgi, et al.
Publicado: (2020)

Assessment of 5% Amlexanox, 0.1% Triamcinolone Acetonide and 0.03% Tacrolimus in the Management of Oral Lichen Planus
por: AlMutairi, Mohammed, et al.
Publicado: (2023)

308-nm excimer lamp with 0.03% tacrolimus ointment is safe and effective to treat children with non-segmental vitiligo
por: Li, Peishan, et al.
Publicado: (2022)

Combination of 0.05% Azelastine and 0.1% Tacrolimus Eye Drops in Children With Vernal Keratoconjunctivitis: A Prospective Study
por: Chen, Minjie, et al.
Publicado: (2021)

DNA Methyltransferases in Malar Melasma and Their Modification by Sunscreen in Combination with 4% Niacinamide, 0.05% Retinoic Acid, or Placebo
por: Campuzano-García, Andres Eduardo, et al.
Publicado: (2019)

Association of Pityriasis Alba with Atopic Dermatitis: A Cross-Sectional Study
por: Gawai, Sonali Ramkrishna, et al.
Publicado: (2021)

Long-term outcomes of 0.1% tacrolimus eye drops in eyes with severe allergic conjunctival diseases
por: Yazu, Hiroyuki, et al.
Publicado: (2021)

Tissue immunostaining for factor XIIIa in dermal dendrocytes of pityriasis alba skin lesions()
por: Carneiro, Francisca Regina Oliveira, et al.
Publicado: (2014)

Analysis of Epidemic Characteristics and Related Pathogenic Factors of 2726 Cases of Pityriasis Alba
por: Lv, Yongmei, et al.
Publicado: (2022)

Acral Persistent Papular Mucinosis with Partial Response to Tacrolimus Ointment
por: Jun, Ji-Young, et al.
Publicado: (2016)

Complete mitochondrial genome of Micractinium singularis MM0003 (Chlorellaceae, Trebouxiophyceae)
por: Jo, Seung-Woo, et al.
Publicado: (2020)

Complete chloroplast genome of Micractinium singularis MM0003 (Chlorellaceae, Trebouxiophyceae)
por: Jo, Seung-Woo, et al.
Publicado: (2020)

p < 0.05, < 0.01, < 0.001, < 0.0001, < 0.00001, < 0.000001, or < 0.0000001 …
por: Zhu, Weimo
Publicado: (2016)

A randomized, multicenter, double-blind study to evaluate the safety and efficacy of estradiol vaginal cream 0.003% in postmenopausal women with dyspareunia as the most bothersome symptom
por: Kroll, Robin, et al.
Publicado: (2018)

Evaluation of the use of tacrolimus ointment for the prevention of hypertrophic scars in experimental model
por: Menezes, Mariana Campos Souza, et al.
Publicado: (2019)

Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement
por: Fukushima, Atsuki, et al.
Publicado: (2014)

To estimate the efficacy of 0.1% tacrolimus with Colgate Oraguard-B paste for the treatment of patients with symptomatic oral lichen planus
por: Nisa, Shams Ul, et al.
Publicado: (2016)

Randomized Mechlorethamine/Chlormethine Induced Dermatitis Assessment Study (MIDAS) Establishes Benefit of Topical Triamcinolone 0.1% Ointment Cotreatment in Mycosis Fungoides
por: Alexander-Savino, Carolina V., et al.
Publicado: (2022)

A randomized triple-blind clinical trial to compare the effectiveness of topical triamcinolone acetonate (0.1%), clobetasol propionate (0.05%), and tacrolimus orabase (0.03%) in the management of oral lichen planus
por: Sivaraman, Shivakumar, et al.
Publicado: (2016)

Topical niacinamide 4% and desonide 0.05% for treatment of axillary hyperpigmentation: a randomized, double-blind, placebo-controlled study
por: Castanedo-Cazares, Juan Pablo, et al.
Publicado: (2013)

Structure properties and dielectric relaxation of Ca(0.1)Na(0.9)Ti(0.1)Nb(0.9)O(3) ceramic
por: Ghoudi, Hanen, et al.
Publicado: (2019)

A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom
por: Archer, David F., et al.
Publicado: (2018)

Expression Levels of Inflammatory and Oxidative Stress-Related Genes in Skin Biopsies and Their Association with Pityriasis Alba
por: Martinez-Fierro, Margarita L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0djr8n1b21e579opu9g84jqge3